Neurofeedback in Treatment of Attention Deficit Hyperactivity Disorder
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 40 people, planned
- Started
- 1 Oct 2025
- Ended
- Feb 2026
- Type of study
- Interventional
- Treatments tested
- Neurofeedback
- Record updated
- 16 December 2025
Who can take part
- Age
- 12 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Participants are between 12- 18 years old
- Both sexes are included (males \& females)
- Willingness to participate to complete study procedures
Who cannot take part
- Other Psychiatric disorders
- Unwilling to participate in the study
- Intellectual disability
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Attention-deficit/hyperactivity disorder (ADHD) is a common , chronic , and debilitating disorder . Although pharmacological treatments for ADHD can be easily implemented and are usually effective, their long-term therapeutic effects are still uncertain and adverse events are common, especially sleep problems, decreased appetite, and growth deceleration. Furthermore, psychosocial treatments, such eas parental training and behavioral therapy seem to be effective only during its delivery, and their effects are rarely sustained long-term .
Read full original descriptionShow less
Neurofeedback is a biofeedback method based on the rationale that there is a relationship between surface EEG and the underlying thalamocortical mechanisms responsible for its rhythms and frequency modulations .
Variations in alertness and behavioural control appear directly related to thalamocortical generator mechanisms. The principle of NF is that over time, participants learn operant control of their EEG and change from an "abnormal" state to one resembling that of typically developing children. This process is thought to eventually remediate the symptoms associated with ADHD .
The group in the trial
- Effectiveness of Neurofeedback in treatment of Attention Deficit Hyperactivity DisorderTreatment being tested
3- Neurofeedback: \- The patients will receive 30 sessions each lasting 50 minutes.
Treatment: Neurofeedback
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effectiveness of Neurofeedback in Treatment of Attention Deficit Hyperactivity Disorder in a Sample of Patients in Tanta, Egypt
- Record updated
- 16 December 2025